Do you want to read an article? Please log in or register.
Measuring disease activity in COPD: is clinically important deterioration the answer?
COPD
RECOMMENDED
Related content
RECOMMENDED
COPD
Preventing Clinically Important Deterioration of COPD with Addition of Umeclidinium to Inhaled Corticosteroid/Long-Acting β2-Agonist Therapy: An Integrated Post Hoc Analysis
Adv Ther.
Naya IP, Tombs L, Lipson DA, Compton C
doi: 10.1007/s12325-018-0771-4.
COPD
The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD
Int J Chron Obstruct Pulmon Dis.
Anzueto AR, Vogelmeier CF, Kostikas K, Mezzi K, Fucile S, Bader G, Shen S, Banerji D, Fogel R
doi: 10.2147/COPD.S133307.
RECOMMENDED
COPD
Objectively measured physical activity as a COPD clinical trial outcome
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Chest
Burtin C, Mohan D, Troosters T, Watz H, Hopkinson NS, Garcia-Aymerich J, Moy ML, Vogiatzis I, Rossiter HB, Singh S, Merrill DD, Hamilton A, Rennard SI, Fageras M, Petruzzelli S, Tal-Singer R, Tomaszewski E, Corriol-Rohou S, Rochester CL, Sciurba FC, Casaburi R, D-C Man W, Van Lummel RC, Cooper CB, Demeyer H, Spruit MA, Vaes A, CBQC Task Force on Physical Activity.
doi: 10.1016/j.chest.2021.06.044
RECOMMENDED
COPD
Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Res.
Rabe KF, Halpin DMG, Han MK, Miravitlles M, Singh D, Grönke L, Voß F, Martinez FJ
doi: 10.1186/s12931-020-01431-y.
COPD
Analysis of nocturnal actigraphic sleep measures in patients with COPD and their association with daytime physical activity
Thorax
Spina G, Spruit MA, Alison J, Benzo RP, Calverley PMA, Clarenbach CF, Costello RW, Donaire-Gonzalez D, Dürr S, Garcia-Aymerich J, van Gestel AJR, Gramm M, Hernandes NA, Hill K, Hopkinson NS, Jarreta D, Kohler M, Kirsten AM, Leuppi JD, Magnussen H, Maltais F, Man WD, McKeough ZJ, Mesquita R, Miedinger D, Pitta F, Singh SJ, Smeenk FWJM, Tal-Singer R, Vagaggini B, Waschki B, Watz H, Wouters EFM, Zogg S, den Brinker AC
doi: 10.1136/
COMMENTED
COPDCough
The association between daily exacerbation symptoms and physical activity in patients with chronic obstructive pulmonary disease
Int J Chron Obstruct Pulmon Dis.
Crook S, Büsching G, Keusch S, Wieser S, Turk A, Frey M, Puhan MA, Frei A
doi: 10.2147/COPD.S156986.
COPD
Physical activity patterns and clusters in 1001 patients with COPD
Chron Respir Dis.
Mesquita R, Spina G, Pitta F, Donaire-Gonzalez D, Deering BM, Patel MS, Mitchell KE, Alison J, van Gestel AJ, Zogg S, Gagnon P, Abascal-Bolado B, Vagaggini B, Garcia-Aymerich J, Jenkins SC, Romme EA, Kon SS, Albert PS, Waschki B, Shrikrishna D, Singh SJ, Hopkinson NS, Miedinger D, Benzo RP, Maltais F, Paggiaro P, McKeough ZJ, Polkey MI, Hill K, Man WD, Clarenbach CF, Hernandes NA, Savi D, Wootton S, Furlanetto KC, Cindy Ng LW, Vaes AW, Jenkins C, Eastwood PR, Jarreta D, Kirsten A, Brooks D, Hillman DR, Sant'Anna T, Meijer K, Dürr S, Rutten EP, Kohler M, Probst VS, Tal-Singer R, Gil EG, den Brinker AC, Leuppi JD, Calverley PM, Smeenk FW, Costello RW, Gramm M, Goldstein R, Groenen MT, Magnussen H, Wouters EF, ZuWallack RL, Amft O, Watz H, Spruit MA
doi: 10.1177/
RECOMMENDED
COPD
Minimal clinically important differences for patient-reported outcome measures of fatigue in patients with COPD after pulmonary rehabilitation
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Chest.
Rebelo P, Oliveira A, Andrade L, Valente C, Marques A
doi: 10.1016/j.chest.2020.02.045.
RECOMMENDED
COPDEmphysema
Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J
Celli B, Locantore N, Yates JC, Bakke P, Calverley PMA, Crim C, Coxson HO, Lomas DA, MacNee W, Miller BE, Mullerova H, Rennard SI, Silverman EK, Wouters E, Tal-Singer R, Agusti A, Vestbo J, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators.
doi: 10.1183/13993003.01339-2020